Saturday, October 24, 2026

I went through all 142 companies in Value Line this morning. Here are the 6 that made it

Six Value Line small caps including Blackbaud, Marqeta, Ranger Energy and Definitive Healthcare trade on net cash, buybacks, low multiples or a takeover bid.

BLKB $2.5BMQ $1.9B

Calvin Blissett Oct 24 79 clicks

Oct 23 EROC $444M

Research & Analysis: ERock, Inc. (NYSE: EROC)

Monte Independent Investment Research 9 clicks

Oct 23 OSCR $9.7B

Oscar Health: Up Over 200% From The March Lows, Still Room To Run (Ticker: OSCR)

Emerging Moats Research 5 clicks

From X

@AsifSuria Sep 21

Asif Suria on X

Imagine what the next line of psychedelic treatments from companies like $HELP and $CMPS will do. Then there is Eli Lilly $LLY with its recent AtaiBeckley acquisition that closed ten days ago. They will be able to put their marketing muscle behind AtaiBeckley's lead candidate (if it gets FDA approval) the way Johnson & Johnson did with Esketamine.

@DOMOCAPITAL Sep 21

DOMO Capital Management, LLC on X

$MNRO must buy all lubricants, non-lubes and service chemicals from Valvoline and can't market competing products. This is an in-depth partnership. Could there be a price increase? Sure, prices have already gone up this year quite a bit, but it won't be the price gouging type of supply that shops with no vendor will be facing. Two main points here. $MNRO is not in danger of running out of supply and if the price does increase, it won't be to the level of competitors without this type of relationship. I had a discussion with a manager at TiresPlus that points to exactly this. Prices so far this year have increased, but he said that the pricing he is getting from vendors he doesn't have a relationship with is multiples higher and he's going to have to pull the trigger with one of them within weeks.

@finphysnerd Sep 21

Myles on X

In Austin trying $CAVA for the first time. Ngl it's pretty good. Not sure it's 80x earnings good, but it's good.

@AsifSuria Sep 21

Asif Suria on X

@Investor_NICK_ @aurelius28 TMS and ketamine made a world of difference to their bottom line. Especially when companies like BrainsWay $BWAY were willing to finance the TMS machines for doctors. https://t.co/Y2bQqX0ALu

@DOMOCAPITAL Sep 21

DOMO Capital Management, LLC on X

And the only reason $MNRO has been hurt is because cost conscious customers have been postponing the services that make all the money (tires, brakes, etc). You can only postpone these items for so long. The demand never goes away.... This is a temporary industry issue and $MNRO is winning market share.

@irbezek Sep 21

Ian Bezek on X

@EconomieReel @jeremie0117 There's not even one poll showing Flavio up. Betting market has gotten way over its skis... I'm long $NU and $INTR but Lula losing is not the default assumption to make imo... https://t.co/NlgYYmcXFu

@irbezek Sep 21

Ian Bezek on X

@valuedrift I was watching this and $GEO rally for months and finally put the short on myself... absolutely silly up here.

@ACapitalLP Sep 21

A Capital on X

Working with Belarus? Interesting. $KYIV https://t.co/VnIEmBNVjw

Trade Alert - Long RIG

HFI Portfolio bought 94,214 shares of Transocean, RIG, for $570,000 at $6.05 per share.

RIG $7.2B

HFI Research Oct 22 10 clicks

MYR Group q3’26 Earnings Preview

MYR Group’s Q3 2026 preview cites data-center and power transmission demand, with long-term service agreements supporting margin growth and…

MYRG $4.2B

Monte Independent Investment Research Oct 22 6 clicks

Mosaic: Cash from Potash Now, a Recovery in Phosphates Later

Mosaic’s potash business generated $930 million after capital spending and closure cash in 2025, while phosphate operations consumed $207…

MOS $5.8B

Latticework by MOI Global Oct 22 13 clicks

Mosaic, Part One: The Story

Mosaic’s history traces the 2004 Cargill-IMC merger and the phosphate and potash mines that shaped NYSE: MOS.

MOS $5.8B

Latticework by MOI Global Oct 22 34 clicks

Mosaic, Part Two: The Deep Dive

Mosaic, NYSE: MOS, is the subject of a second audio program for professional investors analyzing fertilizer producers.

MOS $5.8B

Latticework by MOI Global Oct 22 5 clicks

Undercovered Dozen: Western Digital, Penguin Solutions, Millrose Properties And More

Western Digital, Penguin Solutions and Millrose Properties lead a roundup of 12 lesser-followed stocks featured from Oct. 10 to Oct. 16.

PENG $3.6BMRP $4B

The Undercovered Dozen Oct 22 17 clicks

Unicycive (UNCY):

Unicycive’s oxylanthanum carbonate NDA earned a March 25, 2027 PDUFA date after two manufacturing-related rejections, with no FDA clinical…

UNCY $98M

Triple S Special Situations Investing Oct 22 4 clicks

Group 1 Automotive (GPI) vs Lithia Motors (LAD)

Group 1 Automotive and Lithia Motors divide two longtime value investors: David Abrams switched to Lithia in 2018, while Greg Alexander…

GPI $2.9BLAD $6.3B

Cannibal Stocks Oct 22 6 clicks

Atour Lifestyle ($ATAT): The Hotel Chain That Is Secretly a (Sleep) DTC E-Commerce Brand

Atour Lifestyle combines an asset-light Chinese hotel franchise network with Atour Planet sleep-product sales, using guest rooms as product…

ATAT $4.5B

Substack von Philipp Oct 22 8 clicks

Bumble is being taken private

Bumble agreed to a $6.05-per-share cash sale to Ithaca Holdings, 136% above its October 2 share price.

BMBL $787M

Modern Value Investing Oct 21 8 clicks

PYPD · long

Polypid LTD

PolyPid, an $80 million Israeli biotech, fell nearly 30% despite solving a clinical problem.

PYPD $106M

Value Investors Club Jul 25

This Week in Special Situations: Solstice, Albertsons, Brockhaus, GM

Solstice, Albertsons, Brockhaus and GM anchor a 34-case survey of activism, buybacks, M&A and strategic reviews, led by Starboard’s…

ACI $6.6B

Latticework by MOI Global Oct 22 42 clicks

GLOO, part two

Gloo faces related-party deals, insider-heavy IPO ownership, acquisition losses and $84.5 million of CEO-backed puts as it burns cash and…

GLOO $269M

Guardian Research Oct 21 4 clicks

Webull: A 30% Annual Return Setup As Perpetual Futures Go Live

Webull expects perpetual futures and operating leverage to lift operating income from $114 million to nearly $400 million by 2030.

BULL $3B

PropNotes Oct 21 3 clicks

Why I sold OB pick for 26 SVM

Silvercorp’s falling Ying grades, prolonged GC suspension, El Domo execution risk and Chaarat funding needs weaken its valuation despite…

SVM $1.9B

The Oak Bloke Oct 21 27 clicks

Vicor Update, Part Three

Vicor’s $66.6 million in AI power-delivery royalties generated about $50 million of operating profit, eclipsing its module business as…

VICR $8.1B

CV's Substack Oct 20 28 clicks

Inogen: Cheap Enough To Take A Chance On

Inogen's $45 million buyback, debt-free balance sheet and cash equal to 61% of market value support a Buy case despite 3% 2026 growth…

INGN $189M

Intrinsic Analysis Oct 20 9 clicks

Carecloud News

CareCloud may attract a private-equity buyer after its Q3 call, with acquiring enough shares the main obstacle to a take-private deal.

CCLD $74M

Calvin Blissett Oct 20 11 clicks

From Fat to Follicles - Is Hair Loss the Next Blockbuster?

Novo Nordisk has only floated hair loss, while Veradermics’ Phase 3 oral minoxidil data lead a field of licensing and takeover candidates.

MANE $5.8B

Cestrian Capital Research Oct 20 41 clicks

AGI Inc: The Bargain Is Even More Attractive

AGI Inc trades at 5.6x earnings after a 35% post-IPO decline, despite roughly 30% ROE and resilient INSS payroll-loan growth.

AGBK $790M

Multiplo Invest Oct 20 14 clicks

Saturday, October 24, 2026

Asif Suria on X

DOMO Capital Management, LLC on X

Myles on X

Asif Suria on X

DOMO Capital Management, LLC on X

Ian Bezek on X

Ian Bezek on X

A Capital on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 65 of 259

X accounts we follow

Investor letters we follow

Sectors